Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Update on TERRANOVA Phase III trial for Fasenra in chronic obstructive pulmonary disease
-
Imfinzi significantly improves overall survival in the Phase III PACIFIC trial for unresectable Stage III non-small cell lung cancer
-
AstraZeneca heads to 2018 ASCO Annual Meeting with its diversified oncology portfolio and next-generation pipeline
-
Regulatory submission in Japan for Forxiga in type-1 diabetes
-
Lokelma approved in the US for the treatment of adults with hyperkalaemia
-
Q1 2018 Results
-
New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy ‘as needed’ in mild asthma
-
AstraZeneca is advancing clinical practice in respiratory medicine with new data at the American Thoracic Society 2018 International Congress
-
AstraZeneca provides update on GALATHEA Phase III trial for Fasenra in chronic obstructive pulmonary disease
-
Lynparza tablets receive EU approval for the treatment of platinum-sensitive relapsed ovarian cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
